Skip to content
Agentic OS
Menu

Intelligence / Healthtech / De Novo Grants / BridgeSource Medical Corporation

Approvalsnovel device granted (FDA De Novo)29 Sept 2026

BridgeSource Medical Corporation

29 Sept 2026: Novel device granted (FDA De Novo) · SmartRead(TM) Medical Device Identifier (4100). Recorded in the openFDA device 510(k) (De Novo decisions).

View the source record

Granted
29 Sept 2026
Device
SmartRead(TM) Medical Device Identifier (4100)
Specialty
Cardiovascular
Product Code
SJJ
Country
United States
Location
Austin, TX
Submitted
2026-03-24
Reference
DEN260007
What this signal means

A De Novo grant creates a new device category: reimbursement coding, distribution, clinical evidence, manufacturing scale-up and sales hires follow.

  1. 2 added in the 30 days to 19 Nov 2026.
  2. Neurology leads (10); 29% went to makers outside the US.
Reach them with AOS

Find the decision makers at BridgeSource Medical Corporation

AOS maps the buying committee, finds verified work emails and drafts outreach that cites this approvals signal, for your approval.

Start free

Across AOS Research

Other records for BridgeSource Medical Corporation in our registers.

More in Cardiovascular

De Novo Grants

See all

Source: openFDA device 510(k) (De Novo decisions), data to 19 Nov 2026. Every De Novo classification FDA granted in the last 24 months: a novel device with no legally marketed predicate, which creates a new device type and product code. AOS shows what the public record says; it does not verify or endorse the company.